Conditional Survival in de novo Metastatic Urothelial Carcinoma

BACKGROUND: Second-line therapy is frequently utilized for metastatic urothelial carcinoma, but there are limited data to guide this approach. While an assessment of overall survival based on registry data may not capture the impact of second- and third-line therapies on clinical outcome, this may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Sumanta Kumar, Lin, Yulan Ingrid, Yuh, Bertram, DeWalt, Kara, Kazarian, Austin, Vogelzang, Nicholas, Nelson, Rebecca A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550434/
https://www.ncbi.nlm.nih.gov/pubmed/26308952
http://dx.doi.org/10.1371/journal.pone.0136622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550434/
https://www.ncbi.nlm.nih.gov/pubmed/26308952
http://dx.doi.org/10.1371/journal.pone.0136622

Ejemplares similares